NO920576L - Parenteral doseeringsform - Google Patents

Parenteral doseeringsform

Info

Publication number: NO920576L
Authority: NO; Norway
Prior art keywords: carrier; drug; microspheres; recipient; mixt
Prior art date: 1990-06-14

Application number

NO92920576A

Other languages

English (en)

Other versions

NO920576D0 (no

Inventor

Juan Angeles Uribe

Garza Flores Josue

Original Assignee

Aplicaciones Farmaceuticas

Tripet Marc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-06-14

Filing date

1992-02-13

Publication date

1992-04-08

1992-02-13 Application filed by Aplicaciones Farmaceuticas, Tripet Marc filed Critical Aplicaciones Farmaceuticas

1992-02-13 Publication of NO920576D0 publication Critical patent/NO920576D0/no

1992-04-08 Publication of NO920576L publication Critical patent/NO920576L/no

Links

239000006201 parenteral dosage form Substances 0.000 title 1
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 4
229940079593 drug Drugs 0.000 abstract 4
239000003814 drug Substances 0.000 abstract 4
239000004005 microsphere Substances 0.000 abstract 3
235000012000 cholesterol Nutrition 0.000 abstract 2
LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 abstract 2
239000011261 inert gas Substances 0.000 abstract 2
BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 abstract 2
239000007787 solid Substances 0.000 abstract 2
RXPRRQLKFXBCSJ-GIVPXCGWSA-N vincamine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C[C@](O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-GIVPXCGWSA-N 0.000 abstract 2
DIWRORZWFLOCLC-HNNXBMFYSA-N (3s)-7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound N([C@H](C(NC1=CC=C(Cl)C=C11)=O)O)=C1C1=CC=CC=C1Cl DIWRORZWFLOCLC-HNNXBMFYSA-N 0.000 abstract 1
FQRHOOHLUYHMGG-BTJKTKAUSA-N 3-(2-acetylphenothiazin-10-yl)propyl-dimethylazanium;(z)-4-hydroxy-4-oxobut-2-enoate Chemical compound OC(=O)\C=C/C(O)=O.C1=C(C(C)=O)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 FQRHOOHLUYHMGG-BTJKTKAUSA-N 0.000 abstract 1
108010007979 Glycocholic Acid Proteins 0.000 abstract 1
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
RFDAIACWWDREDC-UHFFFAOYSA-N Na salt-Glycocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCC(O)=O)C)C1(C)C(O)C2 RFDAIACWWDREDC-UHFFFAOYSA-N 0.000 abstract 1
HWHLPVGTWGOCJO-UHFFFAOYSA-N Trihexyphenidyl Chemical group C1CCCCC1C(C=1C=CC=CC=1)(O)CCN1CCCCC1 HWHLPVGTWGOCJO-UHFFFAOYSA-N 0.000 abstract 1
229960001946 acepromazine maleate Drugs 0.000 abstract 1
QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 abstract 1
YSXKPIUOCJLQIE-UHFFFAOYSA-N biperiden Chemical compound C1C(C=C2)CC2C1C(C=1C=CC=CC=1)(O)CCN1CCCCC1 YSXKPIUOCJLQIE-UHFFFAOYSA-N 0.000 abstract 1
229960003003 biperiden Drugs 0.000 abstract 1
DGBIGWXXNGSACT-UHFFFAOYSA-N clonazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl DGBIGWXXNGSACT-UHFFFAOYSA-N 0.000 abstract 1
229960003120 clonazepam Drugs 0.000 abstract 1
238000001816 cooling Methods 0.000 abstract 1
QYIXCDOBOSTCEI-NWKZBHTNSA-N coprostanol Chemical compound C([C@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-NWKZBHTNSA-N 0.000 abstract 1
AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 abstract 1
229960003529 diazepam Drugs 0.000 abstract 1
238000004090 dissolution Methods 0.000 abstract 1
RXPRRQLKFXBCSJ-UHFFFAOYSA-N dl-Vincamin Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)CC(O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-UHFFFAOYSA-N 0.000 abstract 1
229960001253 domperidone Drugs 0.000 abstract 1
FGXWKSZFVQUSTL-UHFFFAOYSA-N domperidone Chemical compound C12=CC=CC=C2NC(=O)N1CCCN(CC1)CCC1N1C2=CC=C(Cl)C=C2NC1=O FGXWKSZFVQUSTL-UHFFFAOYSA-N 0.000 abstract 1
RFDAIACWWDREDC-FRVQLJSFSA-N glycocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 RFDAIACWWDREDC-FRVQLJSFSA-N 0.000 abstract 1
229940099347 glycocholic acid Drugs 0.000 abstract 1
229960003878 haloperidol Drugs 0.000 abstract 1
229960004391 lorazepam Drugs 0.000 abstract 1
239000000155 melt Substances 0.000 abstract 1
238000002844 melting Methods 0.000 abstract 1
230000008018 melting Effects 0.000 abstract 1
229960004503 metoclopramide Drugs 0.000 abstract 1
TTWJBBZEZQICBI-UHFFFAOYSA-N metoclopramide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC TTWJBBZEZQICBI-UHFFFAOYSA-N 0.000 abstract 1
229960005181 morphine Drugs 0.000 abstract 1
238000012216 screening Methods 0.000 abstract 1
239000007921 spray Substances 0.000 abstract 1
238000005507 spraying Methods 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
229960001032 trihexyphenidyl Drugs 0.000 abstract 1
229960002726 vincamine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Compounds Of Unknown Constitution (AREA)
Steroid Compounds (AREA)
Manufacturing Of Micro-Capsules (AREA)

NO92920576A 1990-06-14 1992-02-13 Parenteral doseeringsform NO920576L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9007417A FR2663224B1 (fr)	1990-06-14	1990-06-14	Forme galenique parenterale.
PCT/EP1991/001097 WO1991019485A1 (fr)	1990-06-14	1991-06-12	Forme galenique injectable retardee

Publications (2)

Publication Number	Publication Date
NO920576D0 NO920576D0 (no)	1992-02-13
NO920576L true NO920576L (no)	1992-04-08

Family

ID=9397599

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO92920576A NO920576L (no)	1990-06-14	1992-02-13	Parenteral doseeringsform
NO920576A NO302927B1 (no)	1990-06-14	1992-02-13	Fremgangsmåte for fremstilling av faste ikke-poröse mikrokuler

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO920576A NO302927B1 (no)	1990-06-14	1992-02-13	Fremgangsmåte for fremstilling av faste ikke-poröse mikrokuler

Country Status (33)

Country	Link
US (1)	US5643604A (no)
EP (1)	EP0487674B1 (no)
JP (1)	JP2690398B2 (no)
KR (1)	KR0157438B1 (no)
CN (1)	CN1058608C (no)
AT (1)	ATE117546T1 (no)
AU (1)	AU643540B2 (no)
BG (1)	BG61178B1 (no)
BR (1)	BR9105782A (no)
CA (1)	CA2064861C (no)
CZ (1)	CZ286199B6 (no)
DE (1)	DE69107026T2 (no)
DK (1)	DK0487674T3 (no)
ES (1)	ES2068592T3 (no)
FI (1)	FI107697B (no)
FR (1)	FR2663224B1 (no)
GR (1)	GR3015809T3 (no)
HU (1)	HU219461B (no)
IE (1)	IE69172B1 (no)
IL (1)	IL98458A (no)
NO (2)	NO920576L (no)
NZ (1)	NZ238543A (no)
PH (1)	PH30243A (no)
PL (1)	PL167177B1 (no)
PT (1)	PT97976B (no)
RO (1)	RO110198B1 (no)
RU (1)	RU2095055C1 (no)
SK (1)	SK279867B6 (no)
TN (1)	TNSN91047A1 (no)
TW (1)	TW205511B (no)
UY (1)	UY23239A1 (no)
WO (1)	WO1991019485A1 (no)
ZA (1)	ZA914549B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6090925A (en)	1993-03-09	2000-07-18	Epic Therapeutics, Inc.	Macromolecular microparticles and methods of production and use
US5981719A (en)	1993-03-09	1999-11-09	Epic Therapeutics, Inc.	Macromolecular microparticles and methods of production and use
NZ260408A (en)	1993-05-10	1996-05-28	Euro Celtique Sa	Controlled release preparation comprising tramadol
US5965161A (en)	1994-11-04	1999-10-12	Euro-Celtique, S.A.	Extruded multi-particulates
US6416778B1 (en)	1997-01-24	2002-07-09	Femmepharma	Pharmaceutical preparations and methods for their regional administration
US5993856A (en) *	1997-01-24	1999-11-30	Femmepharma	Pharmaceutical preparations and methods for their administration
US6287693B1 (en) *	1998-02-25	2001-09-11	John Claude Savoir	Stable shaped particles of crystalline organic compounds
GB9819272D0 (en) *	1998-09-03	1998-10-28	Andaris Ltd	Microparticles
WO2000057851A2 (en)	1999-03-26	2000-10-05	Pozen Inc.	High potency dihydroergotamine compositions
DE19940795A1 (de) *	1999-08-27	2001-03-01	Lohmann Therapie Syst Lts	Schnellzerfallende Pellets auf der Basis von Chitosan
EP1297756B1 (de) *	2001-09-27	2005-02-09	Cognis Deutschland GmbH & Co. KG	Kugelförmige Sterinzubereitungen, deren Herstellung und Verwendung
AU2002336653A1 (en) *	2001-10-24	2003-05-06	Luciano Mastronardi	Management of postoperative pain
JP2005513080A (ja) *	2001-12-20	2005-05-12	フェムファーマ，インコーポレイテッド	薬物の膣送達
RU2205634C1 (ru) *	2002-06-18	2003-06-10	Нестерук Владимир Викторович	Лекарственное средство, обладающее противорвотным действием
US7314859B2 (en) *	2002-12-27	2008-01-01	Diobex, Inc.	Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US7655618B2 (en) *	2002-12-27	2010-02-02	Diobex, Inc.	Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US9173836B2 (en)	2003-01-02	2015-11-03	FemmeParma Holding Company, Inc.	Pharmaceutical preparations for treatments of diseases and disorders of the breast
JP2006515026A (ja) *	2003-01-02	2006-05-18	フェムファーマホールディングカンパニー，インコーポレイテッド	乳房の疾患および障害の処置のための薬学的調製物
CA2528545C (en) *	2003-06-13	2014-08-12	John Claude Savoir	Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol
US7413690B1 (en)	2003-10-29	2008-08-19	The University Of Mississippi	Process and apparatus for producing spherical pellets using molten solid matrices
US7491263B2 (en)	2004-04-05	2009-02-17	Technology Innovation, Llc	Storage assembly
SI1838716T1 (sl)	2005-01-05	2011-10-28	Lilly Co Eli	Olanzapin pamoat dihidrat
WO2007072491A2 (en) *	2005-12-21	2007-06-28	Baskaran Chandrasekar	Sustained release pharmaceutical formulation and treatment of ischemic heart disease by administering the same
EP2591675A1 (en)	2006-11-27	2013-05-15	H. Lundbeck A/S	Heteroaryl amide derivatives
US20080153789A1 (en) *	2006-12-26	2008-06-26	Femmepharma Holding Company, Inc.	Topical administration of danazol
CA2721509A1 (en)	2008-04-14	2009-10-22	Posi Visionary Solutions Llp	Method and pharmaceutical composition for obtaining the plasmatic progesterone levels required for different therapeutic indications
RU2395139C1 (ru) *	2009-04-10	2010-07-20	Российская Федерация, от имени которой выступает Государственная корпорация по атомной энергии "Росатом"	Способ изготовления волновода переменного сечения
US20110003000A1 (en) *	2009-07-06	2011-01-06	Femmepharma Holding Company, Inc.	Transvaginal Delivery of Drugs
UY33103A (es)	2009-12-15	2011-07-29	Techsphere S A De C V	Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
RU2012133627A (ru) *	2010-01-14	2014-04-20	Умекрине Муд Аб	Фармацевтическая композиция, содержащая 3-бета-гидрокси-5-альфа-прегнан-20-он, с улучшенными свойствами хранения и растворимости
RU2576236C1 (ru) *	2014-08-22	2016-02-27	Александр Александрович Кролевец	Способ получения нанокапсул антибиотиков в агар-агаре
RU2577689C1 (ru) *	2014-08-26	2016-03-20	Александр Александрович Кролевец	Способ получения нанокапсул антибиотиков в агар-агаре
RU2578408C1 (ru) *	2014-09-10	2016-03-27	Александр Александрович Кролевец	Способ получения нанокапсул алкалоидов
ITUB20153652A1 (it) *	2015-09-16	2017-03-16	Fatro Spa	Microsfere contenenti lattoni macrociclici antielminitici

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE744162A (fr) *	1969-01-16	1970-06-15	Fuji Photo Film Co Ltd	Procede d'encapsulage
US3773919A (en) *	1969-10-23	1973-11-20	Du Pont	Polylactide-drug mixtures
US3937668A (en) *	1970-07-15	1976-02-10	Ilse Zolle	Method for incorporating substances into protein microspheres
DK123067B (da) *	1970-09-25	1972-05-15	Niro Atomizer As	Fremgangsmåde til behandling af et pulverformigt, fedtholdigt mælkeprodukt.
JPS5017525A (no) *	1973-06-14	1975-02-24
US3982537A (en) *	1974-12-30	1976-09-28	Louis Bucalo	Dynamic implants and method for implanting the same
CA1077842A (en) *	1975-10-09	1980-05-20	Minnesota Mining And Manufacturing Company	Albumin medicament carrier system
IT1202370B (it) *	1976-07-12	1989-02-09	Hoffmann La Roche	Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
US4357259A (en) *	1977-08-01	1982-11-02	Northwestern University	Method of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheres
US4244949A (en) *	1978-04-06	1981-01-13	The Population Council, Inc.	Manufacture of long term contraceptive implant
US4331654A (en) *	1980-06-13	1982-05-25	Eli Lilly And Company	Magnetically-localizable, biodegradable lipid microspheres
US4384975A (en) *	1980-06-13	1983-05-24	Sandoz, Inc.	Process for preparation of microspheres
US4349530A (en) *	1980-12-11	1982-09-14	The Ohio State University	Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
FR2524312B1 (fr) *	1982-04-01	1985-10-04	Tech Cuir Centre	Nouvelles formes de micro-encapsulation de substances medicamenteuses par des couches homogenes de collagene natif
US4492720A (en) *	1983-11-15	1985-01-08	Benjamin Mosier	Method of preparing microspheres for intravascular delivery
US4963367A (en) *	1984-04-27	1990-10-16	Medaphore, Inc.	Drug delivery compositions and methods
JPS61174940A (ja) *	1985-01-29	1986-08-06	Oogawara Kakoki Kk	ワックス類コーテイング単核状マイクロカプセルおよびその製造方法
US4675173A (en) *	1985-05-08	1987-06-23	Molecular Biosystems, Inc.	Method of magnetic resonance imaging of the liver and spleen
IL79407A (en) *	1985-08-01	1991-03-10	Theragenics Corp	System and method for delivering insoluble material into a living body
EP0257368B1 (en) *	1986-08-11	1992-03-25	American Cyanamid Company	Compositions for parenteral administration and their use
US4837381A (en) *	1986-08-11	1989-06-06	American Cyanamid Company	Compositions for parenteral administration and their use
CA1319886C (en) *	1987-02-03	1993-07-06	Alberto Ferro	Mixed micelle solutions
US4892734A (en) *	1987-04-06	1990-01-09	Endocon, Inc.	Dispensing paste for forming medicinal pellets
US4748024A (en)	1987-04-06	1988-05-31	Endocon, Inc.	Flash flow fused medicinal implants
EP0357644B1 (en) *	1987-04-06	1994-08-17	Aberlyn Capital Management Limited Partnership	Flash flow fused medicinal implants
EP0366058A3 (en) *	1988-10-27	1991-03-20	Abbott Laboratories	Controlled-release delivery device, method for producing device, and method of using device
US5019400A (en) *	1989-05-01	1991-05-28	Enzytech, Inc.	Very low temperature casting of controlled release microspheres
US5085864A (en) *	1989-10-30	1992-02-04	Abbott Laboratories	Injectable formulation for lipophilic drugs
FR2663223B1 (fr) *	1990-06-14	1994-12-02	Af Aplicaciones Far Lab	Forme galenique parenterale.

1990
- 1990-06-14 FR FR9007417A patent/FR2663224B1/fr not_active Expired - Fee Related
1991
- 1991-06-11 IL IL9845891A patent/IL98458A/en not_active IP Right Cessation
- 1991-06-12 DE DE69107026T patent/DE69107026T2/de not_active Expired - Fee Related
- 1991-06-12 CA CA002064861A patent/CA2064861C/fr not_active Expired - Fee Related
- 1991-06-12 JP JP3510713A patent/JP2690398B2/ja not_active Expired - Lifetime
- 1991-06-12 WO PCT/EP1991/001097 patent/WO1991019485A1/fr not_active Ceased
- 1991-06-12 DK DK91910873.8T patent/DK0487674T3/da active
- 1991-06-12 EP EP91910873A patent/EP0487674B1/fr not_active Expired - Lifetime
- 1991-06-12 HU HU9200775A patent/HU219461B/hu not_active IP Right Cessation
- 1991-06-12 ES ES91910873T patent/ES2068592T3/es not_active Expired - Lifetime
- 1991-06-12 RO RO92-200136A patent/RO110198B1/ro unknown
- 1991-06-12 KR KR1019920700315A patent/KR0157438B1/ko not_active Expired - Fee Related
- 1991-06-12 AU AU80667/91A patent/AU643540B2/en not_active Ceased
- 1991-06-12 RU SU915011663A patent/RU2095055C1/ru active
- 1991-06-12 BR BR919105782A patent/BR9105782A/pt not_active Application Discontinuation
- 1991-06-12 AT AT91910873T patent/ATE117546T1/de not_active IP Right Cessation
- 1991-06-13 IE IE201891A patent/IE69172B1/en not_active IP Right Cessation
- 1991-06-13 UY UY23239A patent/UY23239A1/es not_active IP Right Cessation
- 1991-06-13 SK SK1815-91A patent/SK279867B6/sk unknown
- 1991-06-13 CZ CS19911815A patent/CZ286199B6/cs not_active IP Right Cessation
- 1991-06-14 PL PL91290678A patent/PL167177B1/pl not_active IP Right Cessation
- 1991-06-14 CN CN91104858A patent/CN1058608C/zh not_active Expired - Fee Related
- 1991-06-14 PH PH42634A patent/PH30243A/en unknown
- 1991-06-14 NZ NZ238543A patent/NZ238543A/en not_active IP Right Cessation
- 1991-06-14 TN TNTNSN91047A patent/TNSN91047A1/fr unknown
- 1991-06-14 PT PT97976A patent/PT97976B/pt not_active IP Right Cessation
- 1991-06-14 TW TW080104715A patent/TW205511B/zh active
- 1991-06-14 ZA ZA914549A patent/ZA914549B/xx unknown
1992
- 1992-02-13 NO NO92920576A patent/NO920576L/no unknown
- 1992-02-13 BG BG95911A patent/BG61178B1/bg unknown
- 1992-02-13 NO NO920576A patent/NO302927B1/no not_active IP Right Cessation
- 1992-02-14 FI FI920661A patent/FI107697B/fi active
1993
- 1993-07-14 US US08/094,579 patent/US5643604A/en not_active Expired - Lifetime
1995
- 1995-04-17 GR GR950400939T patent/GR3015809T3/el unknown

Also Published As

Publication number	Publication date
PH30243A (en)	1997-02-05
IL98458A (en)	1995-12-31
PT97976B (pt)	1998-11-30
RO110198B1 (ro)	1995-11-30
SK279867B6 (sk)	1999-04-13
TNSN91047A1 (fr)	1992-10-25
PT97976A (pt)	1992-04-30
HUT61458A (en)	1993-01-28
DK0487674T3 (da)	1995-06-26
BG95911A (bg)	1993-12-24
DE69107026D1 (de)	1995-03-09
EP0487674B1 (fr)	1995-01-25
ES2068592T3 (es)	1995-04-16
NO302927B1 (no)	1998-05-11
ATE117546T1 (de)	1995-02-15
HU219461B (hu)	2001-04-28
UY23239A1 (es)	1991-07-12
FR2663224B1 (fr)	1995-01-20
CZ286199B6 (cs)	2000-02-16
NO920576D0 (no)	1992-02-13
IL98458A0 (en)	1992-07-15
BR9105782A (pt)	1992-08-18
NZ238543A (en)	1993-08-26
GR3015809T3 (en)	1995-07-31
FI920661A0 (fi)	1992-02-14
EP0487674A1 (fr)	1992-06-03
PL290678A1 (en)	1992-06-26
ZA914549B (en)	1992-03-25
IE69172B1 (en)	1996-08-07
CA2064861A1 (fr)	1991-12-15
AU8066791A (en)	1992-01-07
RU2095055C1 (ru)	1997-11-10
FI107697B (fi)	2001-09-28
FR2663224A1 (fr)	1991-12-20
JP2690398B2 (ja)	1997-12-10
CN1057960A (zh)	1992-01-22
CA2064861C (fr)	2000-08-01
KR0157438B1 (ko)	1998-11-16
CS181591A3 (en)	1992-06-17
CN1058608C (zh)	2000-11-22
AU643540B2 (en)	1993-11-18
WO1991019485A1 (fr)	1991-12-26
JPH05501268A (ja)	1993-03-11
KR920702212A (ko)	1992-09-03
IE912018A1 (en)	1991-12-18
US5643604A (en)	1997-07-01
PL167177B1 (pl)	1995-08-31
TW205511B (no)	1993-05-11
DE69107026T2 (de)	1995-08-31
HU9200775D0 (en)	1992-05-28
BG61178B1 (bg)	1997-02-28

Publication	Publication Date	Title
NO920576L (no)	1992-04-08	Parenteral doseeringsform
HU9400186D0 (en)	1994-05-30	Using of n-cyclic and n,n'-dicyclic urea derivatives and process for producing thereof
ZA93929B (en)	1993-09-10	A process for the preparation of biologically active materialcontaining polymeric microcapsules.
CA2148823A1 (en)	1994-05-26	Sustained Release Microsphere Preparation Containing Antipsychotic Drug and Production Process Thereof
ATE94377T1 (de)	1993-10-15	Produkte auf der basis von melaninpigmente enthaltenden polymerpartikeln, verfahren zu ihrer herstellung und ihre verwendung, insbesondere in der kosmetik.
CA2041378A1 (en)	1991-10-29	Granulated preparations and method of producing the same
Kaminsky	1989	Aspects of harmony, rhythm and form in Schumann's Papillons, Carnaval and Davidsbündlertänze
HUT54106A (en)	1991-01-28	Process for producing carboxylic acid amides and pharmaceutical compositions comprising such active ingredient
HUT60509A (en)	1992-09-28	Process for producing monomer and 125 i-marked derivatives of t-butyloxycarbonyl-l-tyrosylpeptidoglycan
HUT45513A (en)	1988-07-28	Process for producing bis(tertiary-butylamino)-1,3,5-triazine derivatives and pharmaceutics comprising the same as active ingredient
HUT65253A (en)	1994-05-02	Process for producing of 1,4-dihydropyridine derivatives and pharmaceutical compositions comprising them
HUT61310A (en)	1992-12-28	Process for producing oxopyrrolo/2,3-b/indoleacetic acids, their esters, amides and derivatives, as well as pharmaceutical compositions comprising such compounds as active ingredient
HUT52071A (en)	1990-06-28	Process for producing 1-amino-alkyl-3-oxy-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-one derivatives and pharmaceutical compositions containing them as active components
HUT53610A (en)	1990-11-28	Herbicides containing derivatives of 5-(3,4,5,6-tetrahydroftalamid)-cinnamon acid and process for production of the active substances
HU907627D0 (en)	1991-06-28	Process for producing diamides of pyridine-2,4 and 2,5-dicarboxylic acid and pharmaceutical preparatives containing these compounds as active substances
PL307395A1 (en)	1995-05-15	3- and 5-substituted 1,2,3,4-oxa-triazolo-5-imine compounds, method of obtaining them, pharmaceutic agent containinmg such compounds and their application in production of drugs
Maksak et al.	1990	Contact of Elements of Alloys With" Shape Memory"
HU907361D0 (en)	1991-07-29	Process for the production of /n-(gamma-glutamyl)-glycyl/-alanine derivatives and medical preparations containing them
CS22989A2 (en)	1991-03-12	Method of epsilon-caprolactam's modified polymers preparation
Mukas'yan et al.	1993	Regularities of structure formation at ignition of titanium in nitrogen
SU1790200A1 (ru)	1996-04-27	Способ получения поликапроамида
HUT54674A (en)	1991-03-28	Process for producing 3,18-dihydroxy-9,13-epoxy-labdane derivatives and pharmaceutical compositions containing them
HU912018D0 (en)	1991-12-30	Process for the production of (1,4)diazepino (3,4-b)kinasolyne-3,7-dion derivatives and their medicative salts, and process for the production of medical products containing the active agents
IL87498A (en)	1993-08-18	Process for the preparation of 3,3(-disubstituted n-substituted b-lactams, and novel compounds obtained thereby
ITBO920133A1 (it)	1993-10-10	Procedimento per la realizzazione di prodotti ceramici antistatici, in particolare piastrelle e prodotto cosi' ottenuto